Abstract Details

Title Correlations of a novel strength-based endpoint for tracking disease progression in amyotrophic lateral sclerosis with quality of life and functioning outcomes

Topic Neuromuscular and Clinical Neurophysiology (EMG)

Presentation(s) P4 - (-)

Poster/Presentation
Number 128

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Jennifer Petrillo Billet, PhD (Sage Therapeutics) PRESENTER	Jennifer Petrillo, 14951 has received personal compensation for serving as an employee of Sage Therapeutics. Jennifer Petrillo, 14951 has received stock or an ownership interest from Sage Therapeutics.
	No disclosure on file
Toby A. Ferguson, MD (Biogen)	Dr. Ferguson has received personal compensation for serving as an employee of Biogen. Dr. Ferguson has received stock or an ownership interest from Biogen.
Steve W. Han, MD PhD (Takeda Pharmaceuticals)	No disclosure on file
Donald Johns, MD (Axon Guidance LLC)	No disclosure on file